目的:通过Meta分析对比单通道内镜及单侧双通道内镜(UBE)在治疗腰椎管狭窄症的临床疗效。方法:检索PubMed、Cochrane Library、Embase和Web of Science等数据库(从建库到2023年10月)对单通道内镜和单侧双通道内镜治疗腰椎管狭窄症疗效...目的:通过Meta分析对比单通道内镜及单侧双通道内镜(UBE)在治疗腰椎管狭窄症的临床疗效。方法:检索PubMed、Cochrane Library、Embase和Web of Science等数据库(从建库到2023年10月)对单通道内镜和单侧双通道内镜治疗腰椎管狭窄症疗效的临床研究进行检索。提取纳入研究的结局指标,包括:腰部和腿部疼痛的VAS评分、术后ODI评分、手术时间、住院天数、并发症发生率、手术优良率。使用Revman 5.3软件对数据进行统计学分析,单个率采用优势比(odds ratios, OR),连续性变量采用加权平均差异(weighted mean difference, WMD),并给出可信区间(confidence interval, CI)为95%。结果:总共有6项研究,515名患者被纳入该Meta分析。UBE手术相对于单通道内镜有着更短的手术时间(WMD −12.37, 95%CI −22.15~−2.6, P = 0.01)。两组患者在腰痛VAS评分[术后第一天(WMD 0.27, 95%CI −0.29~0.82, P = 0.35)、末次随访(WMD −0.02, 95%CI −0.1~0.06, P = 0.63)]、腿痛VAS评分[术后第一天(WMD −0.17, 95%CI −0.43~0.09, P = 0.20)、末次随访(WMD 0.03, 95%CI −0.15~0.15, P = 0.51)、ODI评分(WMD −0.1, 95%CI −0.67~0.47, P = 0.73)、并发症(OR 0.72, 95%CI 0.37~1.41, P = 0.34)、住院天数(WMD −0.06, 95%CI −0.27~0.15, P = 0.56)、手术优良率(OR 1.32, 95%CI 0.69~2.53, P = 0.56)等方面均无明显差异。结论:UBE和单通道内镜治疗腰椎管狭窄症的临床疗效和并发症发生率无明显差异。而UBE与单通道内镜组相比有着更短的手术时间。Objective: To compare the clinical efficacy of uniportal endoscoppic and biportal endoscopic (UBE) decompression for the treatment of lumbar spinal stenosis through meta-analysis. Methods: PubMed, Cochrane Library, Embase and Web of Science databases were searched (from the establishment of the database to October 2023) to compare the clinical studies on the clinical efficacy of uniportal and biportal endoscopy in the treatment of lumbar spinal stenosis. The outcome indicat展开更多
文摘目的:通过Meta分析对比单通道内镜及单侧双通道内镜(UBE)在治疗腰椎管狭窄症的临床疗效。方法:检索PubMed、Cochrane Library、Embase和Web of Science等数据库(从建库到2023年10月)对单通道内镜和单侧双通道内镜治疗腰椎管狭窄症疗效的临床研究进行检索。提取纳入研究的结局指标,包括:腰部和腿部疼痛的VAS评分、术后ODI评分、手术时间、住院天数、并发症发生率、手术优良率。使用Revman 5.3软件对数据进行统计学分析,单个率采用优势比(odds ratios, OR),连续性变量采用加权平均差异(weighted mean difference, WMD),并给出可信区间(confidence interval, CI)为95%。结果:总共有6项研究,515名患者被纳入该Meta分析。UBE手术相对于单通道内镜有着更短的手术时间(WMD −12.37, 95%CI −22.15~−2.6, P = 0.01)。两组患者在腰痛VAS评分[术后第一天(WMD 0.27, 95%CI −0.29~0.82, P = 0.35)、末次随访(WMD −0.02, 95%CI −0.1~0.06, P = 0.63)]、腿痛VAS评分[术后第一天(WMD −0.17, 95%CI −0.43~0.09, P = 0.20)、末次随访(WMD 0.03, 95%CI −0.15~0.15, P = 0.51)、ODI评分(WMD −0.1, 95%CI −0.67~0.47, P = 0.73)、并发症(OR 0.72, 95%CI 0.37~1.41, P = 0.34)、住院天数(WMD −0.06, 95%CI −0.27~0.15, P = 0.56)、手术优良率(OR 1.32, 95%CI 0.69~2.53, P = 0.56)等方面均无明显差异。结论:UBE和单通道内镜治疗腰椎管狭窄症的临床疗效和并发症发生率无明显差异。而UBE与单通道内镜组相比有着更短的手术时间。Objective: To compare the clinical efficacy of uniportal endoscoppic and biportal endoscopic (UBE) decompression for the treatment of lumbar spinal stenosis through meta-analysis. Methods: PubMed, Cochrane Library, Embase and Web of Science databases were searched (from the establishment of the database to October 2023) to compare the clinical studies on the clinical efficacy of uniportal and biportal endoscopy in the treatment of lumbar spinal stenosis. The outcome indicat
